Table 1 Patients with suspected VAP
Overall | Statin previous users | Statin-naive patients | P | |
|---|---|---|---|---|
(n = 349) | (n = 93) | (n = 256) | ||
Age (years) | 64.0 (17.0-94.0) | 68.0 (27.0-90.0) | 63.0 (17.0-94.0) | <0.01 |
SAPS II | 50.0 (6.0-109.0) | 54.0 (18.0-109.0) | 49.0 (6.0-99.0)) | 0.06 |
Gender, male (n (%)) | 254 (72.8) | 80 (86.0) | 174 (68.0) | <0.01 |
Hospitalization prior to ICU admission (n (%)) | 347 (62.3) | 89 (67.9) | 258 (60.6) | 0.14 |
Underlying disease(s) | ||||
COPD (n (%)) | 99 (17.7) | 33 (25.1) | 66 (15.5) | 0.01 |
Chronic renal failure (n (%)) | 23 (6.6) | 10 (10.9) | 13 (5.1) | 0.05 |
Chronic cardiac disease (n (%)) | 138 (39.6) | 65 (70.6) | 73 (28.5) | <0.01 |
Diabetes mellitus (n (%)) | 67 (19.2) | 29 (31.5) | 38 (14.8) | <0.01 |
Cirrhosis (n (%)) | 17 (4.9) | 2 (2.2) | 15 (5.9) | 0.16 |
Immunosuppression (excepting steroids) (n (%)) | 17 (4.9) | 4 (4.3) | 13 (5.1) | 0.78 |
Steroids (n (%)) | 20 (5.8) | 8 (8.7) | 12 (4.7) | 0.16 |
Cancer (n (%)) | 31 (8.9) | 10 (10.9) | 21 (8.2) | 0.44 |
Nursing-home resident (n (%)) | 16 (4.6) | 2 (2.1) | 14 (5.5) | 0.19 |
Main admission diagnosis | 0.20 | |||
Respiratory distress (n (%)) | 133 (38.1) | 33 (35.5) | 100 (39.1) | 0.54 |
Extrapulmonary sepsis (n (%)) | 107 (30.6) | 33 (35.5) | 74 (69.2) | 0.24 |
Neurologic failure (n (%)) | 50 (14.3) | 10 (10.7) | 40 (15.6) | 0.24 |
Abdominal surgery (n (%)) | 17 (4.9) | 2 (2.1) | 15 (5.8) | 0.15 |
Miscellaneous (n (%)) | 42 (12.0) | 15 (16.1) | 27 (10.5) | 0.16 |